Innovations in Cancer Research and Oncology

Continuous Anticancer drug discovery and development is difficult to find a complete cure for cancer. Due to the drug resistance developed by tumour cells for existing treatments, this is becoming a mandatory approach to fight the disease.



Scientific investigations on inhibitors of checkpoint CHK1 can be another milestone for anticancer drug discovery approach.Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.Deregulated apoptosis is hallmark of cancer and Bcl-2 family of proteins are pivotal to mediating the pathway of this process. Inhibiting their process can be a significant way for developing new anticancer drugs. Many plant sources are known to be important sources of novel anti-cancer properties.


    Related Conference of Innovations in Cancer Research and Oncology

    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE

    Innovations in Cancer Research and Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in